A Phase 1, Multiple-dose, Parallel Group Study to Evaluate the Safety and Pharmacodynamic Effects of RDC-0313-buprenorphine (ALKS 33-BUP) Administered Alone and Co-administered With Cocaine to Opioid-experienced Cocaine Abusers
Latest Information Update: 04 Dec 2014
At a glance
- Drugs Buprenorphine/samidorphan (Primary) ; Samidorphan
- Indications Cocaine-related disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Alkermes plc
- 04 Dec 2014 New trial record